L. E. Kaı¨m et al. / Tetrahedron Letters 47 (2006) 8259–8261
8261
4. (a) Faggi, C.; Marcaccini, S.; Pepino, R.; Pozo, M. C.
Synthesis 2002, 18, 2756; (b) Marcaccini, S.; Miliciani, M.;
Pepino, R. Tetrahedron Lett. 2005, 46, 711; (c) Nixey, T.;
Tempest, P.; Hulme, C. Tetrahedron Lett. 2002, 43, 1637.
5. (a) Krelaus, R.; Westermamann, B. Tetrahedron Lett.
2004, 45, 5987; (b) Kazmaeir, U.; Hebach, C.; Watzke, A.;
Maeir, S.; Mues, H.; Huch, V. Org. Biomol. Chem. 2005, 3,
136.
6. Bowman, W. R.; Cloonan, M. O.; Krintel, S. L. J. Chem.
Soc., Perkin Trans. 1 2001, 2885; For general references on
radical chemistry see Radicals in Organic Synthesis;
Renaud, P., Sibi, M. P., Eds.; Wiley-VCH, 2001.
7. (a) Quiclet-Sire, B.; Zard, S. Z. J. Chin. Chem. Soc. 1999,
46, 139; (b) Zard, S. Z. Angew. Chem., Int. Ed. 1997, 36,
672; (c) Zard, S. Z. In Radicals in Organic Synthesis;
Renaud, P., Sibi, M. P., Eds.; Wiley-VCH, 2001; pp 90–
108.
8. (a) Isoherranen, N.; Spiegelstein, O.; Bialer, M.; Zhang, J.;
Merriweather, M.; Yagen, B.; Roeder, M.; Triplett, A. A.;
Schurig, V.; Finell, R. H. Epilepsia 2003, 44, 1280; (b)
Kenda, B. M.; Matagne, A. C.; Talaga, P. E.; Pasau, P.
M.; Differding, E.; Lallemand, B. I.; Frycia, A. M.;
Moureau, F. G.; Klitgaard, H. V.; Gillard, M. R.; Fuks,
B.; Michel, P. J. Med. Chem. 2004, 47, 530–549.
9. Timmer, M. S. M.; Risseeuw, M. D. P.; Verdoes, M.;
Filipov, D. V.; Plaisier, J. R.; van der Marel, G. A.;
Overkleeft, H. S.; van Boom, J. H. Tetrahedron: Asym-
metry 2005, 16, 177.
10. (a) Sato, T.; Ishida, S.; Ishibashi, H.; Ikeda, M. J. Chem.
Soc., Perkin Trans. 1 1991, 353; (b) Udding, J. H.;
Giesselink, J. P. M.; Hiemstra, H.; Speckamp, W. N. J.
Org. Chem. 1994, 5, 6671; (c) Lee, E.; Yoon, C. H.; Lee, T.
H.; Kim, S. Y.; Ha, T. J.; Sung, Y.-S.; Park, S.-H.; Lee, S.
J. Am. Chem. Soc. 1998, 120, 7469; (d) Liu, L.; Chen, Q.;
Wu, Y.-D.; Li, C. J. Org. Chem. 2005, 7, 1539.
11. Typical procedure for 1f: 2,2-dimethyl-4-pentenal (272 lL,
2.0 mmol), 2-methoxyethylamine (174 lL, 2.0 mmol),
chloroacetic acid (189 mg, 2.0 mmol) and t-butyl isocya-
nide (226 lL, 2.0 mmol) were mixed in methanol (2 mL) at
room temperature for 16 h. When the starting material
was totally consumed, potassium O-ethyl xanthate was
added and the resultant mixture was stirred at room
temperature for 1 h. Extraction and purification by flash
column chromatography (silica gel; petroleum ether–
diethyl ether, 30:70) furnished 1f as a white solid (72%
yield).
A solution of this Ugi adduct 1f (242 mg,
0.56 mmol) was then refluxed in 1,2-dichloroethane
(1 mL) for 15 min under argon. Dilauroyl peroxide
(DLP) was then added (10%) to the refluxing solution,
followed by additional portions (5% every 90 min). When
the starting material had been totally consumed (after
addition of 30% of DLP), the crude mixture was cooled
to room temperature, concentrated under reduced pres-
sure and purified by flash column chromatography (silica
gel; petroleum ether–ethyl acetate, 60:40) to afford 2f as a
yellow oil (40% yield). Rf: 0.3 (60:40 petroleum ether/
ethyl acetate).1H NMR (CDCl3, 400 MHz) d 7.45 (br s,
1H), 4.68 (q, 2H, J = 7.1 Hz), 4.42 (dt, 1H, J = 14.3,
2.2 Hz), 4.06 (td, 1H, J = 10.6, 2.2 Hz), 3.80–3.73 (m,
1H), 3.48 (s, 1H), 3.40 (s, 3H), 3.41–3.39 (m, 1H), 3.01–
2.98 (m, 1H), 2.98–2.96 (m, 1H), 2.97–2.93 (m, 1H), 2.45
(ddd, 1H, J = 18.1, 12.9, 5.4 Hz), 2.20 (ddd, 1H,
J = 12.9, 5.4, 2.6 Hz), 1.78 (tdd, 1H, J = 12.9, 5.4,
2.6 Hz), 1.56 (d, 1H, J = 15.4 Hz), 1.44 (t, 3H,
J = 7.1 Hz), 1.31 (s, 9H), 1.25 (s, 3H), 1.14 (s, 3H).13C
NMR (CDCl3, 100.6 MHz) d 213.6, 174.9, 170.2, 72.5,
71.9, 70.0, 59.3, 54.4, 51.2, 43.6, 42.3, 41.2, 34.4, 32.0,
31.0, 28.9, 28.3, 14.2. MS (ID, ICP NH3) m/z 433
(M+H+). HRMS calcd for C20H36N2O4S2: 432.2116,
found: 432.2123.